Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings Call Transcript
Operator Good morning and thank you for standing by. Welcome to Abbott's First Quarter 2023 Earnings Conference Call.
Stay updated with breaking news from Cardiovascular Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator Good morning and thank you for standing by. Welcome to Abbott's First Quarter 2023 Earnings Conference Call.
/PRNewswire/ -- The "United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis"...
/PRNewswire/ -- The "United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis"...
The MESI mTABLET ABI has been chosen as a finalist in the Cardiovascular Devices category in the 2021 Medical Design Excellence Awards competition MESI mTABLET ABI , device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech industry. Since its inception in 1998, the mission of the MDEAs has been to recognize significant achievements in medical product design and engine...
iRhythm Technologies President and CEO Kevin King to Retire; Michael Coyle Joins Company as President and CEO Effective January 12, 2021 December 14, 2020 16:40 ET | Source: iRhythm iRhythm San Francisco, California, UNITED STATES SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective January 12, 2021. Mr. King will continue to serve on iRhyth...